rs7855522
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004560.4(ROR2):c.622+55C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.473 in 1,610,388 control chromosomes in the GnomAD database, including 182,563 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.43 ( 14623 hom., cov: 32)
Exomes 𝑓: 0.48 ( 167940 hom. )
Consequence
ROR2
NM_004560.4 intron
NM_004560.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.60
Publications
8 publications found
Genes affected
ROR2 (HGNC:10257): (receptor tyrosine kinase like orphan receptor 2) The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development. Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]
ROR2 Gene-Disease associations (from GenCC):
- brachydactyly type B1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive Robinow syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-91737336-G-A is Benign according to our data. Variant chr9-91737336-G-A is described in ClinVar as Benign. ClinVar VariationId is 1236286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.483 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ROR2 | ENST00000375708.4 | c.622+55C>T | intron_variant | Intron 5 of 8 | 1 | NM_004560.4 | ENSP00000364860.3 | |||
| ROR2 | ENST00000375715.5 | c.202+55C>T | intron_variant | Intron 5 of 12 | 1 | ENSP00000364867.1 | ||||
| ROR2 | ENST00000550066.5 | n.1090+55C>T | intron_variant | Intron 7 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.429 AC: 65202AN: 151918Hom.: 14623 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
65202
AN:
151918
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.478 AC: 697136AN: 1458352Hom.: 167940 AF XY: 0.477 AC XY: 346137AN XY: 725692 show subpopulations
GnomAD4 exome
AF:
AC:
697136
AN:
1458352
Hom.:
AF XY:
AC XY:
346137
AN XY:
725692
show subpopulations
African (AFR)
AF:
AC:
9921
AN:
33416
American (AMR)
AF:
AC:
18260
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
AC:
12744
AN:
26106
East Asian (EAS)
AF:
AC:
18996
AN:
39674
South Asian (SAS)
AF:
AC:
37252
AN:
86148
European-Finnish (FIN)
AF:
AC:
26807
AN:
52482
Middle Eastern (MID)
AF:
AC:
2303
AN:
5748
European-Non Finnish (NFE)
AF:
AC:
542702
AN:
1109802
Other (OTH)
AF:
AC:
28151
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
19781
39562
59343
79124
98905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
15894
31788
47682
63576
79470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.429 AC: 65206AN: 152036Hom.: 14623 Cov.: 32 AF XY: 0.430 AC XY: 31963AN XY: 74308 show subpopulations
GnomAD4 genome
AF:
AC:
65206
AN:
152036
Hom.:
Cov.:
32
AF XY:
AC XY:
31963
AN XY:
74308
show subpopulations
African (AFR)
AF:
AC:
12612
AN:
41466
American (AMR)
AF:
AC:
6522
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1677
AN:
3470
East Asian (EAS)
AF:
AC:
2382
AN:
5160
South Asian (SAS)
AF:
AC:
2016
AN:
4822
European-Finnish (FIN)
AF:
AC:
5467
AN:
10568
Middle Eastern (MID)
AF:
AC:
93
AN:
292
European-Non Finnish (NFE)
AF:
AC:
33156
AN:
67962
Other (OTH)
AF:
AC:
878
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1908
3816
5725
7633
9541
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
612
1224
1836
2448
3060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1369
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.